Physician profile
Clinton Michael Ray
NPI 1275522740
$1,271.22
in general payments reported to CMS, 2019-2025
15 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $114 · 2021: $172 · 2022: $127 · 2023: $225 · 2024: $115 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $296.30 | 2019-2025 | Aequalis Perform Reversed |
| Ethicon US, LLC | $254.70 | 2021-2025 | Surgiflo Hemostatic Matrix, Vistaseal, Ethicon |
| Depuy Synthes Sales INC. | $243.45 | 2019-2025 | Healix Knotless Peek, Dynacord, Truespan Orthocord |
| Bioventus LLC | $125.32 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Prime Surgical, LLC | $66.83 | 2022-2024 | |
| Heron Therapeutics, INC. | $64.85 | 2022-2023 | Zynrelef |
| Horizon Therapeutics Plc | $55.40 | 2019-2021 | |
| Smith+Nephew, INC. | $52.17 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2024 | |
| Curonix LLC | $15.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cumberland Pharmaceuticals, INC. | $15.45 | 2019 | |
| Orthofix Medical, INC. | $14.87 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.67 | 2021 | |
| Vericel Corporation | $14.34 | 2019 | |
| Medical Device Business Services, INC. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.